The effects of the gonadotrophin releasing hormone analogue (goserelin) and prostaglandin E1 (misoprostol) on cervical resistance prior to transcervical resection of the endometrium
- 1 April 1996
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 103 (4) , 375-378
- https://doi.org/10.1111/j.1471-0528.1996.tb09746.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- A Scottish audit of hysteroscopic surgery for menorrhagia: complications and follow upBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleedingBMJ, 1994
- PROSTAGLANDIN VAGINAL SUPPOSITORIES IN NON PREGNANT WOMEN REQUIRING CERVICAL DILATATION PRIOR TO HYSTEROSCOPYActa Obstetricia et Gynecologica Scandinavica, 1988
- Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.BMJ, 1986
- Study of 91-191-191-1prostaglandin E1 methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal womenAdvances in Contraception, 1985
- Forces required for surgical dilatation of the pregnant and non-pregnant human cervixBJOG: An International Journal of Obstetrics and Gynaecology, 1982